Regenerating the Heart with Stem Cell-Derived Human Cardiomyocytes
This activity has been archived and credit is no longer available.
Dr. Murry will discuss stem cell-based heart regeneration to prevent and reverse heart failure. This recording has been made available from the Texas Heart Institute's Cardiology Grand Rounds series. CME credit is awarded from Texas Heart Institute.
Activity Information
This activity has been archived and credit is no longer available.
Needs Statement
Texas Heart Institute Cardiology Grand Rounds provides a weekly opportunity to learn from leading medical and surgical experts, sharing the latest advancements and innovations in the diagnosis, treatment, and prevention of cardiovascular disease. THI offers complimentary CME credits for participation in Grand Rounds On-Demand.
Educational Objectives
The intended result of this activity is increased knowledge. At the conclusion of this symposium, participants should be able to:
- Identify the principal benefits and risks of cardiomyocyte replacement therapy.
- Distinguish the potential of cardiomyocyte therapy from previously attempted adult cell therapies in cardiac repair.
- Assess the impact of gene editing technologies in understanding and preventing cardiomyocyte engraftment arrhythmias.
Target Audience
Professional Categories
- Physicians
- Fellows
- Residents
- Nurses
- Other Health Professionals
Specialties
- Cardiology
- Thoracic Surgery
Interest Groups
- Hospital Medicine
Activity Director
-
Stephanie Coulter, M.D., FACC, FASE
Clinical Instructor
Texas Heart Institute, Baylor College of Medicine
Term of Approval
September 7, 2022 through September 7, 2024.
Disclosure Policy
Accreditation Information
Additional information about this activity can be found on the accrediting institution's website.
Visit the Activity InformationDisclosures
The following individual(s) has/have reported financial or other relationship(s) with commercial entities whose products/services may relate to the educational content of this activity:
Presenter
-
Charles Murry, M.D., Ph.D.
Professor, William and Marilyn Conner Chair for the Institute for Stem Cell and Regenerative Medicine
University of Washington
Disclosure:
- Employment (with a commercial interest): Sana Biotechnology
Activity Director
-
Stephanie Coulter, M.D., FACC, FASE
Clinical Instructor
Texas Heart Institute, Baylor College of Medicine
Disclosure:
Nothing to disclose.
Health Topics
Presenter: